Home Online Features FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections
FDA Grants Orphan Drug Designation to MicuRx’s MRX-5 for NTM Infections
Press Releases
MicuRx Pharmaceuticals  
January 2, 2025

FDA Grants Orphan Drug Designation to MicuRx’s MRX-5 for NTM Infections

SHANGHAI, Jan. 1, 2025 /PRNewswire/ -- Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx"，688373.SH) announced that MRX-5, its self-developed anti-infection drug, has been granted Orphan Drug Designation (ODD) by the U.S. Food

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social